Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis.
Matthias AugustinAndrea BauerKonstantin ErtnerRalph von KiedrowskiFlorian SchenckJutta Ramaker-BrunkeSophie MöllerAnja FaitMike BastianDiamant ThaçiPublished in: Dermatology and therapy (2023)
DUPILL08907; NIS-Nr. 433.